New Experimental Drug, Vorasidenib, Could Be Advance Against Glioma Brain Tumors

MONDAY, June 5, 2023 -- An experimental targeted therapy can dramatically slow the progress of common slow-growing brain cancers, a new clinical trial finds.
The oral drug vorasidenib nearly tripled progression-free survival in patients with grade...